Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
NBN (Nibrin Nijmegen Breakage Syndrome 1 (Nibrin))
i
Other names:
NBN, Nibrin, Nijmegen Breakage Syndrome 1 (Nibrin), Cell Cycle Regulatory Protein P95, NBS1, NBS, P95, P95 Protein Of The MRE11/RAD50 Complex, Nijmegen Breakage Syndrome Protein 1, AT-V1, AT-V2, ATV
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4683
Related tests:
‹
AmoyDx® HANDLE HRR NGS Panel
BrainTumorNext®
BreastNext®
CancerNext ®
CancerNext-Expanded®
CustomNext-Cancer®
Devyser HBOC NGS
Empower™ Hereditary cancer test
GALEAS™ Hereditary Plus
Invitae Common Hereditary Cancers Panel
Myriad myRisk® Hereditary Cancer
OvaNext®
ProstateNext®
SOPHiA DDM HRD Solution
Tempus xG+
TumorNext-HRD
AmoyDx® HANDLE HRR NGS Panel
BrainTumorNext®
BreastNext®
CancerNext ®
CancerNext-Expanded®
CustomNext-Cancer®
Devyser HBOC NGS
Empower™ Hereditary cancer test
GALEAS™ Hereditary Plus
Invitae Common Hereditary Cancers Panel
Myriad myRisk® Hereditary Cancer
OvaNext®
ProstateNext®
SOPHiA DDM HRD Solution
Tempus xG+
TumorNext-HRD
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
NBN mutation
Solid Tumor
NBN mutation
Solid Tumor
Immunotherapy
Sensitive: B - Late Trials
Immunotherapy
Sensitive
:
B
Immunotherapy
Sensitive: B - Late Trials
Immunotherapy
Sensitive
:
B
NBN mutation
Small Cell Lung Cancer
NBN mutation
Small Cell Lung Cancer
olaparib
Sensitive: C2 – Inclusion Criteria
olaparib
Sensitive
:
C2
olaparib
Sensitive: C2 – Inclusion Criteria
olaparib
Sensitive
:
C2
ROS1 fusion + NBN mutation
Lung Adenocarcinoma
ROS1 fusion + NBN mutation
Lung Adenocarcinoma
sintilimab + niraparib
Sensitive: C4 – Case Studies
sintilimab + niraparib
Sensitive
:
C4
sintilimab + niraparib
Sensitive: C4 – Case Studies
sintilimab + niraparib
Sensitive
:
C4
TMB-L + ARID1A deletion + CDKN2A deletion + CDKN2B deletion + MTAP deletion + PIK3R1 N564D + NBN P81fs*23
Gallbladder Cancer
TMB-L + ARID1A deletion + CDKN2A deletion + CDKN2B deletion + MTAP deletion + PIK3R1 N564D + NBN P81fs*23
Gallbladder Cancer
BMS‐986504
Sensitive: C4 – Case Studies
BMS‐986504
Sensitive
:
C4
BMS‐986504
Sensitive: C4 – Case Studies
BMS‐986504
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.